ArticleBiomolecules2026

Low-Dose Paclitaxel Combined with Dehydrocavidine Synergistically Suppresses Cervical Cancer by Inhibiting FASN/SCD1-Mediated Lipid Metabolism.

Xuelian Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.